446 related articles for article (PubMed ID: 25641356)
1. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
[TBL] [Abstract][Full Text] [Related]
2. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
3. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.
de Torres JP; Bastarrika G; Wisnivesky JP; Alcaide AB; Campo A; Seijo LM; Pueyo JC; Villanueva A; Lozano MD; Montes U; Montuenga L; Zulueta JJ
Chest; 2007 Dec; 132(6):1932-8. PubMed ID: 18079226
[TBL] [Abstract][Full Text] [Related]
4. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
de-Torres JP; Alcaide AB; Campo A; Zulueta JJ; Bastarrika G; Ezponda A; Mesa M; Murillo D; Rodriguez M; Del Mar Ocón M; Felgueroso C; Pueyo J; Lozano MD; Montuenga LM; Berto J; Perez-Warnisher MT; Di-Frisco IM; Seijo LM
Arch Bronconeumol; 2024 Feb; 60(2):95-100. PubMed ID: 38216404
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
[TBL] [Abstract][Full Text] [Related]
6. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
8. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development.
Sanchez-Salcedo P; de-Torres JP; Martinez-Urbistondo D; Gonzalez-Gutierrez J; Berto J; Campo A; Alcaide AB; Zulueta JJ
Lung Cancer; 2016 Jul; 97():28-34. PubMed ID: 27237024
[TBL] [Abstract][Full Text] [Related]
9. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer Screening: Survival in an Extensive Early Detection Program in Spain (I-ELCAP).
Cervera Deval J; Barrios Benito M; Peñalver Cuesta JC; Martínez Pérez E; Sandiego Contreras S; Cruz Mojarrieta J; de Aguiar Quevedo K; Arraras Martínez M; Arana E
Arch Bronconeumol; 2022 May; 58(5):406-411. PubMed ID: 35312494
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
[No Abstract] [Full Text] [Related]
12. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
[TBL] [Abstract][Full Text] [Related]
13. The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.
Jögi J; Markstad H; Tufvesson E; Bjermer L; Bajc M
Int J Chron Obstruct Pulmon Dis; 2015; 10():25-30. PubMed ID: 25565797
[TBL] [Abstract][Full Text] [Related]
14. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
[TBL] [Abstract][Full Text] [Related]
16. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis.
Maldonado F; Bartholmai BJ; Swensen SJ; Midthun DE; Decker PA; Jett JR
Chest; 2010 Dec; 138(6):1295-302. PubMed ID: 20348193
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
Crucitti P; Gallo IF; Santoro G; Mangiameli G
Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
[TBL] [Abstract][Full Text] [Related]
18. COPD phenotypes in a lung cancer screening population.
Balkan A; Bulut Y; Fuhrman CR; Fisher SN; Wilson DO; Weissfeld JL; Sciurba FC
Clin Respir J; 2016 Jan; 10(1):48-53. PubMed ID: 24989058
[TBL] [Abstract][Full Text] [Related]
19. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
[TBL] [Abstract][Full Text] [Related]
20. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
